Stockreport

Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch [Yahoo! Finance]

Petros Pharmaceuticals, Inc.  (PTPI) 
PDF NEW YORK, NY / ACCESSWIRE / January 24, 2024 Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- [Read more]